James N. Kochenderfer

James N. Kochenderfer publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where James N. Kochenderfer sits on this spectrum.

James N. Kochenderfer D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where James N. Kochenderfer sits on this spectrum.

Best Publications

• T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial

  Daniel W Lee;James N Kochenderfer;Maryalice Stetler-Stevenson;Yongzhi K Cui

  3247
  Citations

• Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor

  James N. Kochenderfer;Mark E. Dudley;Sadik H. Kassim;Robert P.T. Somerville

  2096
  Citations

• B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor–transduced T cells

  James N. Kochenderfer;Mark E. Dudley;Steven A. Feldman;Wyndham H. Wilson

  1741
  Citations

• Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma

  Noopur Raje;Jesus Berdeja;Yi Lin;David Siegel

  1708
  Citations

• Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19

  James N. Kochenderfer;Wyndham H. Wilson;John E. Janik;Mark E. Dudley

  1590
  Citations

• Toxicities of chimeric antigen receptor T cells: recognition and management.

  Jennifer N. Brudno;James N. Kochenderfer

  1415
  Citations

• Recent advances in CAR T-cell toxicity: Mechanisms, manifestations and management.

  Jennifer N. Brudno;James N. Kochenderfer

  828
  Citations

• T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma

  Syed Abbas Ali;Victoria Shi;Irina Maric;Michael Wang

  822
  Citations

• T Cells Genetically Modified to Express an Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma

  Jennifer N. Brudno;Irina Maric;Steven D. Hartman;Jeremy J. Rose

  796
  Citations

• Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease

  Jennifer N. Brudno;Robert P.T. Somerville;Victoria Shi;Jeremy J. Rose

  759
  Citations

• B-cell Maturation Antigen Is a Promising Target for Adoptive T-cell Therapy of Multiple Myeloma

  Robert O. Carpenter;Moses O. Evbuomwan;Stefania Pittaluga;Jeremy J. Rose

  716
  Citations

• Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation.

  James N. Kochenderfer;Mark E. Dudley;Robert O. Carpenter;Sadik H. Kassim

  685
  Citations

• Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels

  James N. Kochenderfer;Robert P.T. Somerville;Tangying Lu;Victoria Shi

  593
  Citations

• Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors

  James N. Kochenderfer;Steven A. Rosenberg

  574
  Citations

• Chimeric antigen receptor T-cell therapies for lymphoma

  Jennifer N Brudno;James N Kochenderfer

  518
  Citations

• Construction and preclinical evaluation of an anti-CD19 chimeric antigen receptor.

  James N. Kochenderfer;Steven A. Feldman;Yangbing Zhao;Hui Xu

  501
  Citations

• Adoptive transfer of syngeneic T cells transduced with a chimeric antigen receptor that recognizes murine CD19 can eradicate lymphoma and normal B cells.

  James N. Kochenderfer;Zhiya Yu;Dorina Frasheri;Nicholas P. Restifo

  437
  Citations

• Generation of clinical-grade CD19-specific CAR-modified CD8+ memory stem cells for the treatment of human B-cell malignancies.

  Marianna Sabatino;Jinhui Hu;Michele Sommariva;Michele Sommariva;Sanjivan Gautam

  393
  Citations

• A herceptin-based chimeric antigen receptor with modified signaling domains leads to enhanced survival of transduced T lymphocytes and antitumor activity.

  Yangbing Zhao;Qiong J. Wang;Shicheng Yang;James N. Kochenderfer

  388
  Citations

• A comparison of chimeric antigen receptors containing CD28 versus 4-1BB costimulatory domains.

  Kathryn M Cappell;James N Kochenderfer

  348
  Citations